Methods Mentioned
BETA
biopsies
amputation
Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Nederlands tijdschrift voor geneeskunde
R M BargeJ W van't Wout
Acta otorrinolaringológica española
Pablo Santos GorjónRebeca de la Fuente Cañibano
Medical Mycology Case Reports
Sophie PointElodie Blanchard
Surgery Today
Arvind KumarImmaculata Xess
The Journal of Thoracic and Cardiovascular Surgery
Yukihiro Zaizen, Tatsuya Ohtsu